Exicure, Inc. (XCUR) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Chicago, IL, 美国. 现任CEO为 Jungsoo Kim.
XCUR 拥有 IPO日期为 2018-05-22, 7 名全职员工, 在 NASDAQ Capital Marke, 市值为 $25.22M.
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
